https://biotechmorning.com/news/takeda-zasocitinib-phase-3-psoriasis-results Biotech Morning en 2026-07-17T14:28:51.617Z Takeda's $4 Billion Psoriasis Bet Just Dropped Receipts https://biotechmorning.com/news/kardigan-myokardia-crew-400-million-ipo-2 Biotech Morning en 2026-07-17T14:28:00.890Z The MyoKardia Crew Is Back, and Wall Street Just Handed Them $400 Million https://biotechmorning.com/news/italy-state-backed-angelini-catalyst-rare-disease-deal Biotech Morning en 2026-07-17T14:27:05.257Z Italy Just Bought Its Way Into U.S. Rare Disease https://biotechmorning.com/news/lilly-atabeckley-psychedelics-acquisition Biotech Morning en 2026-07-17T14:26:10.097Z Lilly Just Dropped $3.8 Billion on a Psychedelic Trip https://biotechmorning.com/news/merck-lipfendra-oral-pcsk9-cholesterol-pill Biotech Morning en 2026-07-17T14:25:19.363Z The Cholesterol Pill That Could Kill the Needle https://biotechmorning.com/news/fabhalta-traditional-approval-iga-nephropathy Biotech Morning en 2026-07-17T14:24:24.254Z The Kidney Drug That Just Graduated From Probation https://biotechmorning.com/news/tepezza-loses-ted-monopoly-viridian-lumvoa-approved Biotech Morning en 2026-07-17T14:22:53.986Z Tepezza Just Lost the Throne It's Held for Over Six Years https://biotechmorning.com/news/kalshi-biopharma-prediction-markets-fda Biotech Morning en 2026-07-17T14:21:57.680Z You Can Now Bet Real Money on Whether the FDA Will Approve a Drug https://biotechmorning.com/news/doudna-ai-designed-crispr-enzymes Biotech Morning en 2026-07-17T14:21:01.236Z Jennifer Doudna Just Built CRISPR Enzymes That Evolution Never Imagined https://biotechmorning.com/news/fda-warning-letters-telehealth-compounded-glp1 Biotech Morning en 2026-07-17T14:20:00.917Z The FDA Just Carpet-Bombed 25 Telehealth Companies Over Knockoff Ozempic https://biotechmorning.com/news/sanofi-eu-antitrust-flu-vaccine-marketing Biotech Morning en 2026-07-16T14:25:56.699Z Sanofi Got Caught Trash-Talking a Rival Vaccine https://biotechmorning.com/news/novartis-myricx-bio-adc-acquisition-2 Biotech Morning en 2026-07-16T14:25:06.309Z Novartis Just Paid $1.1 Billion for a Drug That Doesn't Exist Yet https://biotechmorning.com/news/abbvie-apogee-therapeutics-acquisition Biotech Morning en 2026-07-16T14:24:13.770Z AbbVie Just Bet $10.9 Billion on One Molecule. Here's Why. https://biotechmorning.com/news/sobi-gout-drug-fda-manufacturing-rejection Biotech Morning en 2026-07-16T14:23:17.347Z Sobi's Gout Drug Aced Every Test. The FDA Still Said No. https://biotechmorning.com/news/pfizer-penicillin-recall-syphilis-pregnancy-crisis Biotech Morning en 2026-07-16T14:22:24.727Z The One Drug That Stops Babies From Going Blind Just Got Recalled https://biotechmorning.com/news/generic-ozempic-south-africa-sun-pharma Biotech Morning en 2026-07-16T14:21:33.137Z Novo Nordisk's Worst Nightmare Just Landed in South Africa https://biotechmorning.com/news/eye-gene-therapy-easy-win-jnj Biotech Morning en 2026-07-16T14:20:43.000Z The Eye Was Supposed to Be Gene Therapy's Easy Win https://biotechmorning.com/news/fda-approves-first-treg-cell-therapy-tregzi Biotech Morning en 2026-07-16T14:19:41.623Z The FDA Just Created a Whole New Category of Cell Therapy https://biotechmorning.com/news/sarepta-black-box-warning-layoffs-duchenne-2 Biotech Morning en 2026-07-16T14:18:53.437Z Sarepta's Worst Week: Two Deaths, a Black Box, and 500 Pink Slips https://biotechmorning.com/news/oral-wegovy-pill-eu-approval-obesity Biotech Morning en 2026-07-16T14:17:54.450Z The Weight-Loss Pill That Could Replace Your Weekly Injection